AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KJUL 72 min read$VSEE

VSEE HEALTH, INC. (VSEE): Entry into a Material Definitive Agreement

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.4 5 vseeex10-4.htm EXHIBIT 10.4 Exhibit 10.4 THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,

Original reporting
SEC EDGAR 8-K
Published Jul 7, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 7, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefCorporate actions
Primary signal
$VSEE
Neutral
medium confidence
Mentioned
$VSEE
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$VSEENeutralMed
01

Why it matters

The disclosed payment schedule, default interest (22%), and conversion language create a tangible near-term catalyst for credit/liquidity reassessment and potential equity overhang if conversion is triggered.

02

Market read

Traders may reprice VSEE based on the note’s cost, mandatory payments, and default/dilution risk profile.

03

What to watch

Key missing details include the full conversion terms, whether payments are already funded/secured, and how the company’s cash position compares to the scheduled Dec 2026–Apr 2027 payments.

Relevance 6/10Novelty 7/10Timing: post-close filing; traders can reassess liquidity/dilution risk ahead of next payment dates (Dec 15, 2026 onward).

Background

The 8-K reports VSEE’s entry into a material definitive agreement, including a promissory note issued June 18, 2026 to Vanquish Funding Group Inc.

Company-level read

Ticker impact

$VSEENeutralMedium confidence
Context

VSEE entered a material definitive agreement issuing a $295.55k promissory note with 22% default interest and mandatory monthly payments through Apr 2027.

Expected impact

Moderate downside risk if investors view the note as expensive/credit-stressed; upside limited unless conversion/dilution is clearly manageable.

Evidence & confidence

This is a fresh 8-K disclosure of debt terms (amount, maturity, payment schedule, default interest, and conversion language), but the excerpt lacks the full conversion mechanics and whether the note is already funded/used, limiting precision on equity impact.

Market effects

Sector

Adds to the broader micro/small-cap financing narrative where expensive notes can raise perceived balance-sheet risk.

Regional

No clear regional spillover beyond US small-cap credit sentiment.

Global

Limited; this appears company-specific financing with no stated cross-border counterparties beyond the named holder.

Counterpoint

What could challenge this read

The note’s prepayment option (with a declining prepayment percentage) could reduce effective cost if VSEE can refinance quickly, limiting long-run dilution risk.

Key entities

  • issuer
    VSEE Health, Inc.

    Borrower that entered the material definitive agreement and issued the promissory note.

  • counterparty
    Vanquish Funding Group Inc.

    Holder/payee under the promissory note.

Read at source← All news

Related articles

JUL 31
$VSEEMedAI 8/10

VSee Health Signs LOI for Healthcare Platform Acquisition Target With Over $35 Million in Annualized Revenue

VSee Health (NASDAQ:VSEE) said it signed a non-binding letter of intent to acquire healthcare technology and operating assets for a vertically integrated healthcare commerce platform. VSee estimates the deal value at about $42 million, with target annualized revenue over $35 million and about $7 million EBITDA, unaudited. Closing depends on due diligence, definitive agreements, and approvals.

yahoo.com4 min
JUL 31
$VSEEMedAI 8/10

VSee Health to Acquire $35M Healthcare Commerce Platform

VSee Health, Inc. signed a non-binding LOI to acquire healthcare technology and operating assets valued at about $42 million. The target supports a clinic-based wellness commerce platform with an unaudited annual revenue run rate over $35 million and about $7 million in EBITDA. VSee says it would integrate ordering and payment workflows into its API virtual care platform, subject to due diligence and approvals.

hitconsultant.net4 min
JUL 30
$VSEEMed

VSee Health: VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and Mo

VSee Health (NASDAQ:VSEE) said it entered a non-binding letter of intent to acquire certain healthcare technology and operating assets for a vertically integrated healthcare commerce platform. The target assets have an unaudited run rate above $35 million and EBITDA around $7 million. VSee expects a quick close without initial shareholder dilution, subject to due diligence and definitive agreements.

finanznachrichten.de4 min
JUN 5
$VSEEMed

VSEE HEALTH, INC. (VSEE): Completion of Acquisition or Disposition of Assets

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.1 3 vseeex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VSEE HEALTH, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS On May 31, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with

SEC EDGAR 8-K4 min